Issue Date: June 25, 2012
Shifts In Pharma Noted At BIO
The BIO International Convention in Boston last week, sponsored by the Biotechnology Industry Organization, showcased a reviving biotech industry coming to grips with changes in how innovation is funded and drugs are approved and purchased.
The global financial crisis has led the industry’s traditional venture capitalists to pull back on financing. Still, the sector has managed to return to double-digit revenue growth—10% in 2011 compared with 8% in 2010, according to . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society